An experimental COVID-19 pill developed by Japan's Shionogi cut the risk of infection among people exposed to the disease at home. japantimes.co.jp/news/2026/05/… #japan #sciencehealth #shionogi #covid19 #pharmaceuticals #medicine

A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells. japantimes.co.jp/news/2026/05/… #japan #sciencehealth #mhlw #drugs #medicine #parkinson039sdisease #sumitomopharma #ips